Brean Murray Carret & Co.

Brean Murray Carret & Co. is bullish on Electronics For Imaging, Inc. (NASDAQ: EFII), after the company held its analyst day. It has a Buy rating and a $18 price target on shares. In a note to clients, Brean Murray writes, "EFI's Analyst Day left us with increased conviction in our Buy thesis...

Brean Murray Carret & Co. has a $16 price target and a Buy rating on Dell (NASDAQ: DELL), as the computer company acquired a cloud computing company yesterday. In the research note sent to clients, Brean Murray writes, "Yesterday Dell announced its intention to acquire Boomi, a software-as-a...

Brean Murray Carret & Co. has published a research report on Eastman Kodak Company (NYSE: EK) following a softer 3Q that forecasts the possibility that the company may burn exceed operating income as IP litigation continues with Apple (NASDAQ: AAPL) and RIMM (NASDAQ: RIMM), and has upgraded the...

Brean Murray Carret & Co. has a $40 price target on Arrow Electronics, Inc. (NYSE: ARW) and a Buy rating, after the company reported better than expected earnings. In a note to clients, Brean Murray writes, "We see potential upside from the acquisitions. Acquisitions of Nu Horizon and RF are...

Brean Murray, Carret & Co. said that it believes yesterday's 20% sell-off of Lexmark International, Inc. (NYSE: LXK) is an outsized reaction to a handful of items. “We continue to like the stock and view $38 as an attractive level,” Brean Murray, Carret & Co. writes. “While we wouldn't have...

Brean Murray Carret & Co. sees sharp upside in Arrow Electronics, Inc. (NYSE: ARW), as it has a $40 price target and a Buy rating on shares. In a research note, Brean Murray writes, "Looking longer term, Synnex remains our secular favorite given 1) its continued ability to take core SMB...

Brean Murray, Carret & Co. reports that Seagate Technology's (NASDAQ: STX) September quarter revenue of $2.7B was in-line with expectations, “while EPS of $0.37 was lighter than our expectations of $0.45, as gross margins of 20.6% were a little softer than our 22.0% expectation.” Brean Murray,...

Brean Murray Carret & Co. has a Hold rating on shares of Mindray Medical International Limited (NYSE: MR), after the company showcase new products at a Chinese conference during the week. Shares of MR lost $1.16 yesterday to close at $29.94.

Brean Murray Carret & Co. is raising the price target on Seagate (NASDAQ: STX) to $18 from $16, as the company announced yesterday after the bell it had been contacted by private equity firms about a possible transaction. It is reiterating its Buy rating. Shares of STX are up $2.56 to $15.25...

Brean Murray Carret & Co. has resumed coverage for ZHONGPIN, Inc. at Buy with a $21 price target.

Brean Murray Carret & Co. likes shares of SYNNEX Corporation (NYSE: SNX), as it has a Buy rating and a $38 price target on shares. In the research report, Brean Murray writes, "Synnex posted another strong Q, delivering revenue and EPS of $2.17 billion and $0.86 vs. Street consensus of $2.11...

Brean Murray Carret & Co. has initiated coverage for the following companies: Accretive Health Inc. (NYSE: AH) Hold, N/A price target, $10.81 MedAssets, Inc. (NASDAQ: MDAS) Buy, $25 price target, $20.37 Is AAPL a Buy, Sell or Hold? Click Here.

Brean Murray Carret & Co. sees nearly 30% upside in shares of Xerox Corporation (NYSE: XRX), as it sees upside potential in 2011 earnings. It has a Buy rating, and a $14 price target. In the research note, Brean Murray writes, "We can very reasonably envision entering '11 with 1) at least a $1...

Brean Murray has a $50 price target on shares of Hewlett-Packard (NYSE: HPQ) and a Buy rating, after the company agreed to purchase ArcSight (NASDAQ: ARST) for $43.50 per share in cash yesterday. In the research note, Brean Murray writes, "We believe HP was attracted to ArcSight, given 1)...

Brean Murray Carret & Co. has a Hold rating on shares of 1-800 Flowers.Com, Inc. (NASDAQ: FLWS) after the company reported an earnings miss. In the research report, Brean Murray Carret & Co. writes, "We are reiterating our Hold rating, lowering our FY11 EPS and rolling out our FY12 EPS...